Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10.79M | $860.0M | 12.11% | +5.30M | 2026-06-30 |
| Farallon Capital Management, L.L.C. | 8.37M | $666.0M | 9.39% | -- | 2026-06-30 |
| Caligan Partners LP | 8.12M | $647.0M | 9.11% | -- | 2026-06-30 |
| Findell Capital Management LLC | 4.80M | $382.0M | 5.39% | +1.25M | 2026-06-30 |
| Vanguard Capital Management LLC | 3.14M | $250.0M | 3.52% | +212.2K | 2026-06-30 |
| State Street Corp | 3.03M | $241.0M | 3.40% | +1.15M | 2026-06-30 |
| Opaleye Management Inc. | 2.45M | $195.0M | 2.75% | -97.5K | 2026-06-30 |
| Geode Capital Management, LLC | 2.12M | $169.0M | 2.38% | +192.3K | 2026-06-30 |
| Bank of America Corp | 1.99M | $158.0M | 2.24% | -296.2K | 2026-06-30 |
| Citadel Advisors LLC | 1.95M | $155.0M | 2.18% | +30.7K | 2026-06-30 |
